HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth Phillips Selected Research

abacavir (Ziagen)

1/2015Abacavir-reactive memory T cells are present in drug naïve individuals.
1/2015T cell-mediated hypersensitivity reactions to drugs.
1/2015Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.
3/2014Genotyping for severe drug hypersensitivity.
1/2014Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
8/2012HLA and pharmacogenetics of drug hypersensitivity.
1/2009Successful translation of pharmacogenetics into the clinic: the abacavir example.
4/2008High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
2/2008HLA-B*5701 screening for hypersensitivity to abacavir.
1/2008Cytokine profiling in abacavir hypersensitivity patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth Phillips Research Topics

Disease

31Hypersensitivity (Allergy)
01/2022 - 03/2004
8Infections
07/2021 - 07/2007
7Drug-Related Side Effects and Adverse Reactions
01/2021 - 01/2005
6COVID-19
01/2022 - 12/2020
5Stevens-Johnson Syndrome (Lyell's Syndrome)
11/2022 - 08/2012
5Drug Hypersensitivity Syndrome
11/2022 - 03/2004
5Anaphylaxis (Anaphylactic Shock)
01/2022 - 10/2014
5Chemical and Drug Induced Liver Injury
01/2021 - 01/2016
4Parkinson Disease (Parkinson's Disease)
11/2021 - 01/2017
4Dengue (Dengue Fever)
12/2017 - 10/2016
3Neoplasms (Cancer)
09/2019 - 11/2015
3Hepatitis
12/2018 - 01/2005
3Drug Hypersensitivity (Drug Allergy)
05/2015 - 08/2007
2Disease Progression
11/2021 - 09/2019
2Tetanus
01/2018 - 01/2017
2Acquired Immunodeficiency Syndrome (AIDS)
05/2017 - 01/2005
2HIV Infections (HIV Infection)
01/2017 - 09/2009
2Tuberculosis (Tuberculoses)
01/2016 - 08/2015
2Hepatitis C
02/2008 - 07/2007
1Glioma (Gliomas)
08/2022
1Astrocytoma (Pilocytic Astrocytoma)
08/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2022
1Atherosclerosis
07/2022
1Stroke (Strokes)
01/2022
1Whooping Cough (Pertussis)
11/2021
1Torsades de Pointes (Torsade de Pointes)
01/2021
1Hemolytic Anemia
01/2021
1Thrombotic Microangiopathies
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Thrombosis (Thrombus)
01/2021
1Yellow Fever
11/2020
1Cicatrix (Scar)
11/2019
1Leukemia
09/2019
1Cholestasis
09/2019
1Jaundice (Icterus)
09/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
12/2018
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2018
1Cardiomyopathies (Cardiomyopathy)
01/2018

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
11/2022 - 09/2004
16abacavir (Ziagen)FDA Link
01/2015 - 03/2004
12HLA-B Antigens (HLA-B)IBA
01/2021 - 03/2004
8EpitopesIBA
07/2022 - 01/2017
7AntigensIBA
11/2021 - 09/2004
6HLA-B57 antigenIBA
11/2019 - 01/2014
6Nevirapine (Viramune)FDA Link
01/2015 - 01/2005
5VaccinesIBA
01/2022 - 01/2017
5Peptides (Polypeptides)IBA
12/2017 - 06/2012
4SynucleinsIBA
11/2021 - 01/2017
3Anti-Bacterial Agents (Antibiotics)IBA
07/2021 - 12/2013
3mRNA VaccinesIBA
01/2021 - 01/2021
3Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2017
3Carbamazepine (Tegretol)FDA LinkGeneric
11/2019 - 03/2014
3HLA-DRB1 Chains (HLA DRB1)IBA
10/2016 - 01/2005
3Penicillins (Penicillin)FDA Link
09/2015 - 05/2015
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2015 - 04/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 03/2004
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2022 - 01/2017
2CytokinesIBA
07/2022 - 01/2008
2COVID-19 VaccinesIBA
01/2022 - 01/2021
2Allopurinol (Remid)FDA LinkGeneric
01/2021 - 01/2015
2HLA-A Antigens (HLA-A)IBA
01/2021 - 12/2018
2Tetanus Toxoid (Vaccine, Tetanus)FDA Link
01/2018 - 01/2017
2Attenuated VaccinesIBA
12/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2008
2Isoniazid (Ftivazide)FDA LinkGeneric
01/2016 - 08/2015
1alpha-hydroxyglutarateIBA
08/2022
1Choline (Choline Chloride)IBA
08/2022
1Inositol (Myoinositol)IBA
08/2022
1Apolipoproteins B (ApoB)IBA
07/2022
1AutoantigensIBA
11/2021
1carfilzomibIBA
01/2021
1Proteasome InhibitorsIBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Herpes Zoster VaccineIBA
11/2020
1HLA-A31 antigenIBA
11/2019
1pegaspargase (Oncaspar)FDA Link
09/2019
1EnzymesIBA
09/2019
1Antineoplastic Agents (Antineoplastics)IBA
09/2019
1Asparaginase (Elspar)FDA Link
09/2019
1Cephalosporins (Cephalosporin Antibiotics)IBA
09/2019
1Dyphylline (Diprophylline)FDA Link
09/2019
1Alkaline PhosphataseIBA
12/2018
1Alanine Transaminase (SGPT)IBA
12/2018
1Terbinafine (Lamisil)FDA LinkGeneric
12/2018
1protein phosphatase 4IBA
01/2018
1LaminsIBA
01/2018
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018

Therapy/Procedure

4Therapeutics
09/2019 - 07/2007
2Drug Therapy (Chemotherapy)
01/2018 - 10/2017
2Precision Medicine
11/2015 - 08/2007
1Secondary Prevention
01/2022
1Duration of Therapy
01/2022
1Patient Transfer (Patient Dumping)
01/2022
1Injections
01/2021
1Premedication
01/2021
1Liver Transplantation
12/2018